Skip to main content
TipRanks
Go Ultimate75% OFF

Steminent Biotherapeutics, Inc. (7729) Balance Sheet

Steminent Biotherapeutics, Inc. Balance Sheet

Steminent Biotherapeutics, Inc.'s total assets for Q2 2026 were NT$1.10B, an increase of 57.82% from the previous quarter. TW:7729 total liabilities were NT$92.89M for the fiscal quarter, a 4.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 698.49MNT$ 436.66MNT$ 593.88MNT$ 235.65MNT$ 279.50M
NT$ 97.34MNT$ 81.97MNT$ 100.89MNT$ 72.11MNT$ 35.23M
NT$ 601.15MNT$ 354.70MNT$ 492.99MNT$ 163.54MNT$ 244.27M

Currency in TWD

Steminent Biotherapeutics, Inc. Liabilities to Assets

0250M500M750M0 %40 %80 %120 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets